- abnormal motor capabilities/coordination/movement / MGI
- ataxia / MGI
- impaired coordination / MGI
- decreased glucagon secretion / MGI
- decreased insulin secretion / MGI
- abnormal pancreatic beta cell physiology / MGI
- decreased synaptic glutamate release / MGI
- abnormal miniature excitatory postsynaptic currents / MGI
- behavior/neurological phenotype / MGI
- taste/olfaction phenotype / MGI
- decreased prepulse inhibition / MGI
C3;C-Snap25Bdr/H
Status | Available to order |
EMMA ID | EM:01844 |
International strain name | C3;C-Snap25Bdr/H |
Alternative name | GENA70 |
Strain type | Induced Mutant Strains : Chemically-induced |
Allele/Transgene symbol | Snap25Bdr |
Gene/Transgene symbol | Snap25 |
Information from provider
Provider | Pat Nolan |
Provider affiliation | MRC Mammalian Genetics Unit |
Genetic information | Point mutation resulting in a subtle ataxic gait from weaning age, 10-20% smaller than littermates |
Phenotypic information | Homozygous mutants die at P1, heterozygous mutants show subtle ataxic gait from weaning age, 10-20% smaller than littermates |
References |
|
Information from EMMA
Archiving centre | Mary Lyon Centre at MRC Harwell, Oxford, United Kingdom |
Disease and phenotype information
MGI allele-associated human disease models
Orphanet associated rare diseases, based on orthologous gene matching
- Presynaptic congenital myasthenic syndromes / Orphanet_98914
MGI phenotypes (allele matching)
MGI phenotypes (gene matching)
- increased white adipose tissue amount / MGI
- myoclonus / MGI
- tremors / MGI
- thin diaphragm muscle / MGI
- abnormal cerebral cortex morphology / MGI
- convulsive seizures / MGI
- abnormal skin condition / MGI
- increased body weight / MGI
- decreased body weight / MGI
- decreased body size / MGI
- delayed eyelid opening / MGI
- increased anxiety-related response / MGI
- abnormal locomotor behavior / MGI
- ataxia / MGI
- hyperactivity / MGI
- hypoactivity / MGI
- no spontaneous movement / MGI
- impaired coordination / MGI
- abnormal object recognition memory / MGI
- abnormal spatial learning / MGI
- unresponsive to tactile stimuli / MGI
- disheveled coat / MGI
- increased circulating triglyceride level / MGI
- hyperglycemia / MGI
- abnormal blood vessel morphology / MGI
- decreased embryo size / MGI
- abnormal dopamine level / MGI
- infertility / MGI
- respiratory failure / MGI
- seizures / MGI
- abnormal motor capabilities/coordination/movement / MGI
- increased circulating insulin level / MGI
- premature death / MGI
- abnormal brain morphology / MGI
- no abnormal phenotype detected / MGI
- abnormal CNS synaptic transmission / MGI
- abnormal intercostal muscle morphology / MGI
- hepatic steatosis / MGI
- akinesia / MGI
- decreased glucagon secretion / MGI
- decreased vertical activity / MGI
- increased thigmotaxis / MGI
- blotchy skin / MGI
- abnormal PNS synaptic transmission / MGI
- abnormal endplate potential / MGI
- enhanced paired-pulse facilitation / MGI
- decreased paired-pulse facilitation / MGI
- no phenotypic analysis / MGI
- decreased insulin secretion / MGI
- decreased width of hypertrophic chondrocyte zone / MGI
- abnormal pancreatic beta cell physiology / MGI
- abnormal insulin secretion / MGI
- decreased synaptic glutamate release / MGI
- abnormal miniature excitatory postsynaptic currents / MGI
- increased circulating cholesterol level / MGI
- improved glucose tolerance / MGI
- abnormal serotonin level / MGI
- insulin resistance / MGI
- behavior/neurological phenotype / MGI
- taste/olfaction phenotype / MGI
- increased susceptibility to diet-induced obesity / MGI
- increased circulating leptin level / MGI
- increased body mass index / MGI
- impaired hearing / MGI
- abnormal hippocampus CA3 region morphology / MGI
- increased white fat cell size / MGI
- decreased prepulse inhibition / MGI
- abnormal impulsive behavior control / MGI
- postnatal lethality, incomplete penetrance / MGI
- neonatal lethality, complete penetrance / MGI
- decreased circulating ghrelin level / MGI
- increased food intake / MGI
- decreased food intake / MGI
Literature references
- A systematic, genome-wide, phenotype-driven mutagenesis programme for gene function studies in the mouse.;Nolan P M, Peters J, Strivens M, Rogers D, Hagan J, Spurr N, Gray I C, Vizor L, Brooker D, Whitehill E, Washbourne R, Hough T, Greenaway S, Hewitt M, Liu X, McCormack S, Pickford K, Selley R, Wells C, Tymowska-Lalanne Z, Roby P, Glenister P, Thornton C, Thaung C, Stevenson J A, Arkell R, Mburu P, Hardisty R, Kiernan A, Erven A, Steel K P, Voegeling S, Guenet J L, Nickols C, Sadri R, Nasse M, Isaacs A, Davies K, Browne M, Fisher E M, Martin J, Rastan S, Brown S D, Hunter J, ;2000;Nature genetics;25;440-3; 10932191
- A dominant mutation in Snap25 causes impaired vesicle trafficking, sensorimotor gating, and ataxia in the blind-drunk mouse.;Jeans Alexander F, Oliver Peter L, Johnson Reuben, Capogna Marco, Vikman Jenny, Molnár Zoltán, Babbs Arran, Partridge Christopher J, Salehi Albert, Bengtsson Martin, Eliasson Lena, Rorsman Patrik, Davies Kay E, ;2007;Proceedings of the National Academy of Sciences of the United States of America;104;2431-6; 17283335
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).